Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Generation of recombinant yellow fever virus (strain 17d) vaccine vectors to deliver heterologous antigens

Objective

Generation of yellow fever virus (vaccine strain 17D) recombinants capable of expressing heterogonous antigens during their viral replication cycle, and characterisation of the immunological responses generated by the recombinant vectors.

Fields of science (EuroSciVoc)

Topic(s)

Call for proposal

Data not available

Funding Scheme

BUR - Bursaries, grants, fellowships

Coordinator

PIERRE FABRE MEDICAMENT S.A.
EU contribution
No data
Address
Avenue Napoléon III , 5 Le Puy Saint Martin
74164 SAINT JULIEN-EN-GENEVOIS
France
Total cost
No data